Related references
Note: Only part of the references are listed.Synthesis of Double Interfering Biodegradable Nano-MgO Micelle Composites and Their Effect on Parkinson's Disease
Mingchao Li et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2021)
Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice
Yang Han et al.
BIOACTIVE MATERIALS (2021)
Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy
Shuang Feng et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2020)
A Self-Assembled α-Synuclein Nanoscavenger for Parkinson's Disease
Jingyi Liu et al.
ACS NANO (2020)
Lipid-based nanodelivery approaches for dopamine-replacement therapies in Parkinson's disease: From preclinical to translational studies
Govindarajan Karthivashan et al.
BIOMATERIALS (2020)
Dual and multi-targeted nanoparticles for site-specific brain drug delivery
Yan Luo et al.
JOURNAL OF CONTROLLED RELEASE (2020)
A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice
Qian Guo et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Ultrasound-responsive neurotrophic factor-loaded microbubble- liposome complex: Preclinical investigation for Parkinson's disease treatment
Chung-Yin Lin et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Self-assembled polydopamine nanoparticles improve treatment in Parkinson's disease model mice and suppress dopamine-induced dyskinesia
Long Binh Vong et al.
ACTA BIOMATERIALIA (2020)
Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson's disease management
Piyong Sola et al.
EXPERT OPINION ON DRUG DELIVERY (2020)
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs
Saba Naqvi et al.
FRONTIERS IN NEUROSCIENCE (2020)
Melatonin/polydopamine nanostructures for collective neuroprotection-based Parkinson's disease therapy
Anup K. Srivastava et al.
BIOMATERIALS SCIENCE (2020)
Biomimetic drug-delivery systems for the management of brain diseases
Yao-xing Chen et al.
BIOMATERIALS SCIENCE (2020)
Gold nanoclusters for Parkinson's disease treatment
Guanbin Gao et al.
BIOMATERIALS (2019)
Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier
Garima Sharma et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Micro- and nanotechnology approaches to improve Parkinson's disease therapy
Pablo Vicente Torres-Ortega et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Non-viral nucleic acid delivery to the central nervous system and brain tumors
Shanshan Wang et al.
JOURNAL OF GENE MEDICINE (2019)
Current status and perspectives of zinc-based absorbable alloys for biomedical applications
David Hernandez-Escobar et al.
ACTA BIOMATERIALIA (2019)
Human gene therapy approaches for the treatment of Parkinson's disease: An overview of current and completed clinical trials
Frederick L. Hitti et al.
PARKINSONISM & RELATED DISORDERS (2019)
Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease
Takuya Uehara et al.
SCIENTIFIC REPORTS (2019)
Biodegradable Manganese-Doped Calcium Phosphate Nanotheranostics for Traceable Cascade Reaction-Enhanced Anti-Tumor Therapy
Lian-Hua Fu et al.
ACS NANO (2019)
Biocompatible Semiconductor Quantum Dots as Cancer Imaging Agents
Kevin J. McHugh et al.
ADVANCED MATERIALS (2018)
A brain targeting functionalized liposomes of the dopamine derivative &ITN&IT-3, 4-bis(pivaloyloxy)-dopamine for treatment of Parkinson's disease
Mengke Qu et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model
Walhan Alshaer et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Promoting neuroregeneration by applying dynamic magnetic fields to a novel nanomedicine: Superparamagnetic iron oxide (SPIO)-gold nanoparticles bounded with nerve growth factor (NGF)
Muzhaozi Yuan et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Neuroprotective effect of gold nanoparticles composites in Parkinson's disease model
Kaikai Hu et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Graphene quantum dots prevent α-synucleinopathy in Parkinson's disease
Donghoon Kim et al.
NATURE NANOTECHNOLOGY (2018)
Tyrosine hydroxylase as a sentinel for central and peripheral tissue responses in Parkinson's progression: Evidence from clinical studies and neurotoxin models
M. E. Johnson et al.
PROGRESS IN NEUROBIOLOGY (2018)
Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's disease
Vinay Sridhar et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in Parkinson's Disease
Farhang Aliakbari et al.
NANOSCALE (2018)
Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases
Christos Tapeinos et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Hydrophilic, mesoporous structural ZnO nanospheres for pH-triggered release of drug
Boshi Tian et al.
MATERIALS LETTERS (2017)
Biocompatible curcumin loaded PMMA-PEG/ZnO nanocomposite induce apoptosis and cytotoxicity in human gastric cancer cells
Raman Dhivya et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)
Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model
Brian P. Mead et al.
NANO LETTERS (2017)
Zinc as a Neuromodulator in the Central Nervous System with a Focus on the Olfactory Bulb
Laura J. Blakemore et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Maltodextrin modified liposomes for drug delivery through the blood-brain barrier
Zeynep Gurturk et al.
MEDCHEMCOMM (2017)
Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model
Shuiqin Niu et al.
THERANOSTICS (2017)
Highly luminescent, heteroatom-doped carbon quantum dots for ultrasensitive sensing of glucosamine and targeted imaging of liver cancer cells
Rahul Kumar Das et al.
JOURNAL OF MATERIALS CHEMISTRY B (2017)
Decreased circulating Zinc levels in Parkinson's disease: a meta-analysis study
Ke Du et al.
SCIENTIFIC REPORTS (2017)
Zinc and Copper Effects on Stability of Tubulin and Actin Networks in Dendrites and Spines of Hippocampal Neurons
Laura Perrin et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Self-Assembled ZnO Nanoparticle Capsules for Carrying and Delivering Isotretinoin to Cancer Cells
Wei Zhao et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
ZnO-Based Nanoplatforms for Labeling and Treatment of Mouse Tumors without Detectable Toxic Side Effects
Dai-Xin Ye et al.
ACS NANO (2016)
Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice
Yang Liu et al.
BIOMATERIALS (2016)
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
Mahdi Karimi et al.
CHEMICAL SOCIETY REVIEWS (2016)
Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier
Debora B. Vieira et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles
Lin Wei et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Crossing the blood-brain barrier: Glutathione-conjugated poly(ethylene imine) for gene delivery
Christoph Englert et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Dual-Mechanism Antimicrobial Polymer-ZnO Nanoparticle and Crystal Violet-Encapsulated Silicone
Sacha Noimark et al.
ADVANCED FUNCTIONAL MATERIALS (2015)
Exosomes as drug delivery vehicles for Parkinson's disease therapy
Matthew J. Haney et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Synergistically enhanced photocatalytic and chemotherapeutic effects of aptamer-functionalized ZnO nanoparticles towards cancer cells
Zhou Han et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2015)
Pharmacological Treatment of Parkinson Disease A Review
Barbara S. Connolly et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Hyaluronic Acid Conjugates as Vectors for the Active Targeting of Drugs, Genes and Nanocomposites in Cancer Treatment
Silvia Arpicco et al.
MOLECULES (2014)
Current Progress in Gene Delivery Technology Based on Chemical Methods and Nano-carriers
Lian Jin et al.
THERANOSTICS (2014)
ZnO Nanoparticles Applied to Bioimaging and Drug Delivery
Huan-Ming Xiong
ADVANCED MATERIALS (2013)
Biodegradable ZnO@polymer CoreShell Nanocarriers: pH-Triggered Release of Doxorubicin In Vitro
Zheng-Yong Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier
Ja-Young Kim et al.
BIOMATERIALS (2013)
Non-Viral Nanosystems for Gene and Small Interfering RNA Delivery to the Central Nervous System: Formulating the Solution
Aoife M. O'Mahony et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Recent Advances in the Genetics of Parkinson's Disease
Ian Martin et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 12 (2011)
ZnO QD@PMAA-co-PDMAEMA nonviral vector for plasmid DNA delivery and bioimaging
Peng Zhang et al.
BIOMATERIALS (2010)
Photoluminescent ZnO nanoparticles modified by polymers
Huan-Ming Xiong
JOURNAL OF MATERIALS CHEMISTRY (2010)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Share Paper
